ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 86 filers reported holding ENZO BIOCHEM INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $585,000 | -68.2% | 142 | -60.0% | 0.00% | – |
| Q2 2018 | $1,842,000 | -5.3% | 355 | 0.0% | 0.00% | – |
| Q1 2018 | $1,945,000 | -32.8% | 355 | 0.0% | 0.00% | – |
| Q4 2017 | $2,893,000 | -22.2% | 355 | 0.0% | 0.00% | – |
| Q3 2017 | $3,717,000 | -5.4% | 355 | -0.3% | 0.00% | – |
| Q2 2017 | $3,930,000 | +31.9% | 356 | 0.0% | 0.00% | – |
| Q1 2017 | $2,980,000 | +148900.0% | 356 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -99.6% | 356 | -99.6% | 0.00% | -100.0% |
| Q2 2016 | $488,000 | -80.1% | 81,731 | -84.9% | 0.00% | -66.7% |
| Q1 2016 | $2,456,000 | -18.1% | 539,867 | -19.0% | 0.00% | 0.0% |
| Q4 2015 | $2,999,000 | +42.7% | 666,391 | +0.5% | 0.00% | +50.0% |
| Q3 2015 | $2,101,000 | +3.4% | 662,851 | -1.2% | 0.00% | 0.0% |
| Q2 2015 | $2,032,000 | +85.4% | 670,770 | +80.6% | 0.00% | +100.0% |
| Q1 2015 | $1,096,000 | – | 371,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |